Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 215-284-3 | CAS number: 1318-23-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Based on read-across:
Skin irritation
-LAB Research Ltd., Study 09/164-006N (OECD TG# 404) [Al(OH)3 powder, Klimisch=1], test substance is not a skin irritant
-Lansdown (1973), [Al(OH)3 suspension, Klimisch=2] no guideline study, test substance is not a skin irritant
Eye irritation
-LAB Research Ltd., Study 09/164-006N (OECD TG# 405) [Al(OH)3 powder, Klimisch=2], test substance is not a eye irritant
Key value for chemical safety assessment
Skin irritation / corrosion
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Additional information
There are no studies available, which investigate the skin and eye irritant properties of Bohmite. Thus, information available on supporting substances was taken into account by read-across following a structural analogue approach as well. Aluminium compounds were considered for this approach, since the pathways leading to toxic outcomes are dominated by the chemistry and biochemistry of the aluminium ion (Al3+) (Krewski et al.,2007).
Skin irritation
An animal study of aluminium hydroxide conducted in accordance with OECD TG #404 (Lab Research Ltd., 2009) provides key evidence for the absence of acute dermal irritation effects on exposure to this substance. Supporting evidence is available from an earlier animal study of aluminium hydroxide powder conducted in accordance with OECD TG 404 “Acute Dermal Irritation/Corrosion” (1989) aluminium hydroxide (Aluminium hydroxide, IUCLID, 2000). A full report of this study is not available for review. A negative result from a non-guideline animal study that applied aluminium hydroxide solution (10%) (Lansdown, 1973) daily for five consecutive days also contributes to the weight of evidence for a lack of irritative or corrosive effects according to Regulation (EC) No. 1272/2008.
Eye irritation
The negative results from the LAB Research Ltd. Study (2009) on aluminium hydroxide support a lack of irritant properties of aluminium hydroxide on acute eye exposure. This study is a key in the weight of evidence assessment. The negative results of the key study are supported by an animal study conducted according to OECD TG 405 “Acute Eye Irritation/Corrosion” (1989) (Aluminium hydroxide, IUCLID, 2000). The studies showing negative results for skin irritation also contribute to the weight of evidence. Overall, the weight of evidence suggests a lack of chemical irritant properties for aluminium hydroxide dust on acute eye exposure.
Respiratory irritation
Human Studies
Results from two studies that examined cross-shift lung effects among aluminium reduction workers (Chan-Yeunget al.,1983; Kilburn and Warshaw, 1989) provide insufficient evidence for an acute, irritative, substance-specific effect from inhalation of aluminium oxide particulates in this occupational setting.
Airborne exposures in the potroom are multiple – several of which may contribute to a pulmonary response. The evidence suggests a role for aluminium fluoride (AlF3), cryolite
(Na4AlF6), or hydrogen fluoride (HF) in the causation of observed lung effects (ATSDR, 2008; Krewskiet al., 2007; Sorgdrageret al., 1995; Soyseth and Kongerud, 1992; Kongerud, 1992). Co-exposure to nickel and the extremely high, accidental exposure levels cannot be excluded as contributory to the toxic pneumonia and fibrosis found in a thermal sprayer (20% aluminium and 80% nickel metal content; Schalleret al., 2007). Results from three studies that examined cross-shift lung effects among aluminium-exposed welders (Kilburnet al., 1989; Fishwicket al., 2004; Gubeet al., 2009) provide insufficient evidence for an acute, irritative, substance-specific effect from inhalation of aluminium oxide fume.
No studies were located that reported acute lung effects in workers from short-term inhalation exposure to aluminium hydroxide dust. Results from cross-sectional studies among bauxite-exposed workers are inconclusive concerning a respiratory irritative effect associated with the cumulative exposure levels encountered in the workplace (Beachet al.,2001; Fritschiet al.2001/2003; Townsendet al., 1985, 1988). Threats to the validity of the available studies include possible selection biases due to cross-sectional designs, residual confounding by smoking, possibly irritative co-exposures, and the lack of measurements of the respirable fraction.
Animal Studies
Pauluhn (2009a) observed an inflammatory response in BALF cytology and biochemistry that was mild and to some degree reversible in a subacute study in rats exposed by inhalation to agglomerated nano-sized aluminium oxyhydroxide particulates. The inflammatory response after 10 days of exposure was significant at the highest dose of 28 mg/m³ but was not detectable at 0.4 and 3 mg/m³. Lindenschmidt et al.(1990) administered single doses of 10 and 50 mg/kg bw Al2O3to Fischer 344 rats by intratracheal instillation (ITI). Responses to crystalline silica and TiO2were also examined and compared with a saline control. At 50 mg/kg bw, both Al2O3and TiO2exhibited early changes in BAL biochemistry and cells consistent with a mild inflammatory response. All values returned to baseline by 9 weeks post-treatment. For the 10 mg/kg bw level, values had returned to normal 2 weeks post-treatment. Tornlinget al.(1993) compared BAL biochemistry in Sprague-Dawley rats on single intratracheal instillation of primary or secondary alumina. Only the fluoride-containing secondary alumina exhibited a reversible, short-term inflammatory response. Fibronectin was elevated in both the primary and secondary alumina-treated groups at the end of the study suggesting a role of the alumina component in the development oflonger-term effects. White et al.(1987) compared BAL biochemistry, BAL cell counts, and lung tissue biochemistry in male Fischer 344 rats exposed to virginal alumina or potroom dust in a short-term, single ITI dose study. The effects of the alumina were typical of a nuisance dust with no evidence of an acute inflammatory response.
Summary
Overall, the current evidence for an acute irritative effect on inhalation exposure to aluminium oxide or bauxite from human studies does not support a chemical-specific irritative effect. The evidence from animal studies and in-vitro studies also does not support a chemical-specific irritative effect. Based on the available data, aluminium oxide and aluminium hydroxide dust are low cytotoxicity “nuisance dusts” with mild, respiratory irritant effects on acute exposure.
Justification for classification or non-classification
Based on the read-across from aluminium and other aluminium compounds as structural analogues, the available data on skin, eye and respiratory irritation for Boehmite are conclusive but not sufficient for classification according to DSD (67/548/EEC) or CLP (1272/2008/EC)classification criteria
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.